Help shape the future of global AMR evidence and policy!
Complete this 15-minute survey
The Quadripartite organizations (FAO, UNEP, WHO, WOAH) will establish the Independent Panel on Evidence for Action against AMR (IPEA) later this year. IPEA’s overarching objective is to “facilitate the generation and use of multisectoral, scientific evidence to support Member States in efforts to tackle antimicrobial resistance”.
Founding documents outlining the Terms of Reference, Modalities for selection of members, Conflict of interest policy and Process for determining the work program have been developed by the Quadripartite Joint Secretariat. At this stage, further engagement of the scientific community could benefit the Expert Committee in shaping IPEA’s future scientific work program.
This virtual expert consultation process aims to identify scientific priorities for the global assessment of AMR. It offers an opportunity to explore which priority AMR topics are best positioned to be assessed through IPEA’s work program in the short-(1-2 years) and medium-term (3-5 years).
This survey is part of a larger study conducted by the Global Strategy Lab, in partnership with the International Network for AMR Social Science (INAMRSS) and IMPACT AMR, and is not a formal consultation process from the Quadripartite Joint Secretariat on AMR. Virtual expert dialogues were held on September 29th and 30th, 2026, but participation in this survey is open to all AMR experts, regardless of whether they participated in these virtual dialogues.
Interested in contributing? You will be asked to review information about the study and provide consent before completing the survey. The information gathered through the survey will be used to publish a policy brief and a peer-reviewed publication capturing the scientific priorities for IPEA as identified by the AMR scientific community.
Thank you again for your time and valuable contributions to help inform the future of global AMR evidence and policy.
If you have any questions, about the research in general or your role in the study, please contact:
Dr. Lauren Wallace, Research Associate, Global Strategy Lab, lauren.wallace@globalstrategylab.org
This research has received ethics review and approval by the Human Participants Review Sub-Committee, York University Ethics Board (Project #1165) and conforms to the standards of the Canadian Tri-Council Research Ethics guidelines. If you have any questions about this process, or about your rights as a participant in the study, please contact the Manager, Research Ethics in the Office of Research Ethics, York University (e-mail ore@yorku.ca). This office oversees the ethical conduct of research studies and is not part of the study team. Everything that you discuss will be kept confidential.
Previous